Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis by Steenblock, Charlotte et al.








Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the
neuroendocrine stress axis
Steenblock, Charlotte ; Todorov, Vladimir ; Kanczkowski, Waldemar ; Eisenhofer, Graeme ; Schedl,
Andreas ; Wong, Ma-Li ; Licinio, Julio ; Bauer, Michael ; Young, Allan H ; Gainetdinov, Raul R ;
Bornstein, Stefan R
DOI: https://doi.org/10.1038/s41380-020-0758-9






The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Steenblock, Charlotte; Todorov, Vladimir; Kanczkowski, Waldemar; Eisenhofer, Graeme; Schedl, An-
dreas; Wong, Ma-Li; Licinio, Julio; Bauer, Michael; Young, Allan H; Gainetdinov, Raul R; Bornstein,
Stefan R (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine
stress axis. Molecular Psychiatry, 25(8):1611-1617.
DOI: https://doi.org/10.1038/s41380-020-0758-9
Molecular Psychiatry (2020) 25:1611–1617
https://doi.org/10.1038/s41380-020-0758-9
GUEST EDITORIAL
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and
the neuroendocrine stress axis
Charlotte Steenblock 1 ● Vladimir Todorov1 ● Waldemar Kanczkowski1 ● Graeme Eisenhofer1,2 ● Andreas Schedl3 ●
Ma-Li Wong 4 ● Julio Licinio4 ● Michael Bauer 5 ● Allan H. Young6 ● Raul R. Gainetdinov7,8 ● Stefan R. Bornstein1,9
Received: 21 April 2020 / Revised: 23 April 2020 / Accepted: 23 April 2020 / Published online: 7 May 2020
© Springer Nature Limited 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), first identified in December 2019, causes coronavirus dis-
ease 2019 (COVID-19). It is reasonable to presume that
SARS-CoV-2 infection will cause activation of the endocrine
stress axis at several levels. The endocrine stress system
involves communication among different tissues, including
among others, the brain and components of the hypothalamic-
pituitary-adrenal (HPA) axis. Dysregulation of the stress
system leads to morphologic changes in target organs or epi-
genetic stem cell changes. These in turn might contribute to the
development or exacerbation of various psychiatric disorders.
We discuss here the potential impact of an infection such as
SARS-CoV-2 on a systemic level and reflect on its potential
influence on the endocrine stress axis and the consequent long-
term consequences. As SARS-CoV-2 and its host receptor,
angiotensin-converting enzyme 2 (ACE2), both impact the
HPA axis, we also discuss potential therapeutic strategies.
How humans cope with distinct stressors is crucial for
their health as imbalance of the stress response can impact
the development of disease and the course of psychiatric
disorders. Among the latter, major depression, anxiety dis-
orders, and the occupational burnout syndrome may also
contribute to somatic manifestations such as inflammatory,
immune, oncologic, metabolic, and cardiovascular disorders
(reviewed in [1–5]).
COVID-19, caused by SARS-CoV-2, may lead to a full
cascade of stress responses. This can be expected to include
activation of the neuroendocrine HPA stress axis and other
systems that maintain homeostasis. Foremost amongst these
is the renin-angiotensin-aldosterone system (RAAS), which
is directly impacted by SARS-CoV-2 [6]. Therefore, for
infected patients there is need to consider potential com-
plications or benefits for treatments that target regulatory
endocrine systems, including drugs such as corticosteroids,
ACE inhibitors, or angiotensin receptor blockers [7–10].
Apart from infected patients, others may also suffer the
consequences of SARS-CoV-2. In addition to anxiety of
getting or being infected, stress may be associated with the
loss of family members or friends, patient care, or with
quarantine measures. Downstream consequences, such as
emotional and financial instability are also likely to impact
mental health and from this also the associated somatic
disorders. Therefore, numerous considerations relevant to
mental health and general well-being need to be anticipated
during and after a pandemic and resulting quarantine mea-
sures, such as what is occurring in COVID-19 [11].
Stress response
The ability of an organism to adapt to encountered stressors
involves the sympathoadrenal system and the HPA axis,
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and interactions between these two systems play a central
role in adaptation. Patients with stress-related disorders may
exhibit increased vulnerability to mental illness for several
years after the stress experience [12].
On a systemic level, stressors activate the sympathetic
branch of the autonomic nervous system followed by acti-
vation of the HPA axis. Splanchnic nerve activation triggers
chromaffin cells in the adrenal medulla to release the cate-
cholamines, epinephrine and norepinephrine, for mediating
a rapid response. When the HPA axis is activated,
corticotropin-releasing hormone (CRH) and arginine vaso-
pressin (AVP) are secreted from the paraventricular nucleus
of the hypothalamus. CRH and AVP then activate the
anterior pituitary to secrete adrenocorticotropic hormone
(ACTH), which in turn stimulates the adrenal cortex to
produce corticosteroids [13].
Glucocorticoid receptors are expressed in several areas of
the adult brain such as the hypothalamus, pituitary, hippo-
campus, and amygdala, which are all involved in gluco-
corticoid feedback. An appropriate response during acute
stress is imperative for survival, but frequent or prolonged
activation can change the functional tone of stress systems
with ensuing deleterious effects.
Excessive or chronic activation of the endocrine stress
axis, which also leads to a disrupted feedback loop, triggers
and contributes to numerous human disorders and stress
conditions in humans, including anxiety, post-traumatic
stress disorder, major depressive disorder, and occupational
burnout. In addition, gonadal steroids can differentially
affect the HPA axis resulting in sex differences in responses
to stress [14]. Animal models and human studies support an
increased risk in males for behavioral or neurodevelop-
mental disorders in response to prenatal and early life stress,
whereas females appear to have an increased risk in ado-
lescence and throughout adulthood, especially if they have
experienced stress-related early life adversity or trauma.
During the perimenopause and menopausal transition,
women are at greater risk for presenting with affective
disorders including depression as well as schizophrenia
[15].
Infection with SARS-CoV-2
Entry of the corona viruses SARS-CoV and SARS-CoV-2
into cells depends on binding of the viral spike (S) glyco-
proteins to cellular ACE2, which the virus uses as its entry
receptor. Furthermore, S proteins are primed by host cell
proteases [16, 17]. This subsequently leads to fusion of the
viral envelope and the plasma membrane or the endosome
membrane of the host. It has been indicated that the SARS-
CoV-2 S protein binds to ACE2 with 10–20-fold higher
affinity than the S protein of SARS-CoV. This might
underlie the high spread of SARS-CoV-2 [18].
ACE2 is a carboxypeptidase, which controls the gen-
eration of the vasodilating angiotensin 1–7 from angiotensin
II. ACE2 can also cleave angiotensin I to angiotensin 1–9,
which can then be further converted to angiotensin 1–7 by
ACE. ACE2, angiotensin 1–7 and its MAS receptor con-
stitute the vasoprotective arm of the RAAS. Excessive
activation of the classical RAAS leads to arterial hyper-
tension, accompanied by immuno-metabolic disorders and
obligatory culminates in end-organ damage in the absence
of adequate therapy (for recent reviews see [19–23]). The
RAAS and in particular ACE2 appear to be attractive targets
to fight COVID-19. Therein, the role of ACE inhibitors and
AT1R blockers is currently highly controversial. On the one
hand, these drugs could increase ACE2 expression and
potentiate SARS-CoV-2 cell entry [24]. On the other hand,
increased ACE2 production would result in a higher cir-
culating level of soluble ACE2, which neutralizes SARS-
CoV-2 [25]. Yet, the precise role of the available RAAS-
targeting drugs in COVID-19 disease waits to be unraveled.
ACE2 has been shown to have an effect on the stress
response and on anxiety. Mice overexpressing ACE2 are
less anxious and have reduced plasma corticosterone and
pituitary expression of proopiomelanocortin [26]. The same
effect was observed when ACE2 overexpression was tar-
geted to the CRH-synthesizing cells of the hypothalamus
suggesting that especially the HPA axis is affected [27]. In
mice transgenic for ACE2, the olfactory bulb of the brain is
a major target organ for SARS infection leading to trans-
neural spread [28–30].
Expression of ACE2 has been noted not only in the
respiratory tract, lung, ileum, bladder, esophagus, heart, and
kidney [31], but also in the the hypothalamus, pituitary and
adrenal [32]. These results fit with the organ distribution of
SARS-CoV observed in patients who died of SARS [33].
Intriguingly, in these patients, following the lung, the
adrenal belonged to the organs with the highest concentra-
tion of virus particles. In addition, the pituitary was affected
[33] making it clear that the HPA axis is targeted during a
coronavirus infection. Furthermore, the gastrointestinal tract
is targeted [33] suggesting associations with appearance of
gastrointestinal infection symptoms in some patients [34].
As ACE2 is also expressed in the human brain this might
explain why infection of the central nervous system is
regularly observed in SARS patients [35, 36].
Although an equal number of COVID-19 cases between
men and women has been reported, there seem to be sex
differences in mortality and vulnerability to the disease [37].
Emerging evidence suggests that more men than women are
dying [38, 39]. It has been speculated that this is due to sex-
based immunological [40] or other differences, such as
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patterns and prevalence of smoking [41]. An alternative
hypothetical explanation could involve sex-dependent differ-
ences in responsiveness of HPA and other hormonal/stress
systems. Further research is needed to confirm this hypothesis.
In conclusion, the strong interaction and reciprocal
communication between the organs of the endocrine stress
system in a coronavirus infection require a deeper under-
standing of the adaptation of all components to the infec-
tion. Furthermore, it has to be considered that certain
therapies impacting expression of ACE2 might also influ-
ence the RAAS and the neuroendocrine stress axis, which
may lead to long-term consequences, as prolonged exposure
to stressors increases the risk to develop major depressive,
anxiety and post-traumatic stress disorders [42].
SARS-CoV-2 antiviral defense
Maintenance of homeostasis during immune challenges,
such as a virus infection, involves activation of the immune
system, resolution of the challenge, and protection of the
host against potentially toxic inflammatory processes. Upon
immune challenge, the immune system is activated to pro-
duce a number of cytokines. One functional group of
cytokines mediates the innate immune response and
includes several proinflammatory cytokines: tumor necrosis
factor-α (TNF-α), interleukin-1 (IL-1), and IL-6, and the
type I interferons (IFN-α/β). These cytokines are released in
the early stages of an immune response. Another group of
cytokines, such as the T cell cytokines IL-2 and IFN-γ (type
II interferons), which are especially important in mediating
antiviral defenses, mediates the later adaptive immunity.
In addition to contributing to the progression of the
immune response against viral infection, cytokines activate
the HPA axis, resulting in the release of adrenal gluco-
corticoids [43]. In turn, glucocorticoids exert negative
feedback influences on immune cells to suppress further
synthesis and release of cytokines, thereby protecting the
host from the detrimental consequences of an overactive
immune response (e.g., tissue damage, autoimmunity, or
septic shock) [44, 45]. A number of cytokines have been
measured in serum of COVID-19 patients [46]. Initial
plasma IL-1B, IL-1RA, IL-7, IL-8, IL-9, IL-10, bFGF,
GCSF, GMCSF, IFN-γ, IP-10, MCP1, MIP-1A, MIP-1B,
PDGF, TNF-α, and VEGF concentrations were higher in
patients than in healthy adults, whereas plasma levels of IL-
5, IL-12p70, IL-15, Eotaxin, and RANTES were
similar in patients and controls. IFN-α and β were not
measured. These results suggest that an overproduction of
cytokines might be responsible for the damage of the
lungs in COVID-19 patients. However, also host factors
such as expression of ACE2 and underlying diseases such
as hypertension, chronic obstructive pulmonary disease,
diabetes, and cardiovascular disorders might influence
susceptibility to infection and progression of the
disease [34, 47].
Both SARS-CoV and Middle East respiratory syndrome
(MERS)-CoV were shown to induce very little type I IFN in
most cell types. This might be due to different reasons such
as storage of coronaviral dsRNA in double-membrane
vesicles and activation of numerous mechanisms dedicated
to suppress dsRNA-dependent IFN induction [48]. This
explains how these viruses employ mechanisms to escape,
dampen, or block the antiviral interferon response in human
cells. Furthermore, the ability of certain pathogens to escape
from host immune response has been reported to be
accomplished by host protein mimicry [49]. Thereby, no or
a limited amount of antibodies are created, which also
explains why certain vaccines may be ineffective. On the
other hand, the similarity between pathogenic antigens and
host proteins may lead to immune cross reactivity, whereby
the reaction of the immune system toward the pathogenic
antigens may harm similar human proteins, eventually
causing autoimmune disease [50].
It has been proposed that an escape mechanism of
SARS-CoV could be accomplished by viral expression of
amino acid sequences mimicking ACTH. When the host
produces antibodies against these viral antigens, the anti-
bodies also bind to ACTH thereby limiting HPA activity
and secretion of corticosteroids, which could lead to adrenal
insufficiency [51]. This suggests that corticosteroids may be
used to treat COVID-19 patients thereby helping the
immune system to fight the infection. Indeed, corticosteroid
supplements have improved the clinical conditions of many
SARS patients [52]. On the other hand, a number of studies
reported corticosteroid-treatment of SARS patients to be
rather harmful (reviewed in [53]). For example, early steroid
treatment has been associated with delayed viral clearance
[54], and it has been found that patients with psychosis
received higher cumulative doses of steroids than patients
without psychosis [55]. In a study with 138 COVID-19
patients, where 45% received methylprednisolone, no
effective outcome was observed after the treatment [56].
Thereby, the use of corticosteroids for the treatment of
COVID-19 is not recommended [34].
SARS-CoV-2 infection and psychological
stress
As mentioned above an infection with SARS-CoV-2 can be
expected to lead to activation of the endocrine stress axis in
association with mental stress. In addition, to the actual
infection and treatment, psychological stress is likely to
occur due to pandemic restrictions. Isolation during a pan-
demic is somewhat similar to physical immobilization
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stress, which leads to increased expression of enzymes
involved in steroidogenesis [57] and elevated plasma cor-
ticosteroids [58]. Chronic restraint stress in rats also alters
the RAAS by reduction of plasma aldosterone levels despite
significant increases in plasma renin activity. Public anxiety
of being infected is high; health care workers, who have
higher vulnerability of acquiring and spreading the virus,
are in particular those most likely to be distressed. In a study
about the impact of MERS in health care workers in Saudi
Arabia, a significant proportion expressed anxiety about the
risk of acquiring MERS-CoV infection and for transmitting
it to family members [59, 60].
In addition, during quarantine or curfew, people might
experience loneliness because of the lack of communica-
tion and engagement with others. Loneliness, defined as
the discrepancy between a person’s desired and actual
social relationships, is an emotional response to social
isolation, while social isolation is an objective measure of
the lack of social connections or interactions [61, 62].
Social isolation and loneliness are common sources of
chronic stress in adults. They are correlated to a higher risk
of mortality and cardiovascular disease, which have been
associated with activation of the HPA axis and the sym-
pathetic nervous system. Repeated and chronic social
stress leads to glucocorticoid release, enhanced myelo-
poiesis, upregulated proinflammatory gene expression, and
oxidative stress [63]. Furthermore, psychological stress
due to social isolation is known to cause abnormal feeding
behaviors. In addition to psychological reactions, such as
depression and anxiety, stress triggers various physiolo-
gical reactions including an increase in respiration and
blood pressure. An activated stress axis also influences the
body’s metabolism [64, 65]. In particular, changes in
feeding behavior are a well-known phenotype related to
stress [66].
People who survived an infection with SARS-CoV have
shown elevated stress levels long after the outbreak [67].
Leow et al. observed a direct effect on the HPA axis in
SARS survivors 3 months after their recovery, where
hypocortisolism was diagnosed. One year after recovery,
HPA dysfunction had largely recovered [68]. However,
even though physical conditions continuously improved,
mental health did not. Psychiatric morbidities and chronic
fatigue persisted and continued to be clinically significant
up to at least 4 years after the SARS outbreak [69]. This has
also been shown by Lee et al., where health care workers
during the outbreak showed an elevated stress level when
compared to non-health care workers. One year later, stress
levels of survivors remained persistently elevated and
higher than in control subjects. Specifically, health care
workers showed significantly higher stress levels and had
even higher depression, anxiety, and post-traumatic symp-
tom scores than other survivors [70, 71].
The role of stem cells in COVID-19
Progenitor and stem cell populations are required for the
successful homeostasis and adaptation of most tissues. Stem
cells are dynamically regulated by signals originating from
their niches, helping to regulate appropriate proliferation
and differentiation. External and internal stressors influence
the process of cell differentiation of stem and progenitor
cells in the HPA axis in order to form the fully functional
endocrine stress system [72].
In relation to coronavirus infections, it was shown that
pulmonary stem/progenitor cells that express ACE2 are
targeted by SARS-CoV in primary cultures [73]. The
infected cells support active virus replication, which leads to
their own destruction [73]. Another study by Mallick et al.
has further revealed that a subset of these stem cells, the
bronchoalveolar stem cells, are the prime target of the
SARS-CoV infection of stem cells [74]. These observations
suggest that, in addition to pneumocytes, lung stem cells/
progenitors are involved in coronavirus infection. This
might also explain the long course of illness, in the context
of continued deterioration of lung tissues and apparent loss
of capacity of lung repair observed in COVID-19 patients.
As, after the lung, the adrenal is one of the most pro-
minent organs infected by coronavirus. It would be rea-
sonable to hypothesize that in a manner analogous to what
happens in the lung, stem cells of the HPA axis could be
affected by SARS-CoV-2. We and others have shown that
stem cells play an important role in stress [75, 76]. Our
work on the adrenal suggests that stem cell populations in
both the adrenal cortex and medulla are highly susceptible
to stress [77, 78]. Under normal conditions, they seem to be
quiescent or only slowly contribute to organ homeostasis.
However, in stressful situations they enter the cell cycle
leading to differentiation into mature lineages. Furthermore,
we have shown that differentiation of adrenocortical stem
cells is faster in females than in males [79].
In a recent paper, de Laval et al. have shown that a
transient immune challenge with lipopolysaccharide not
only induced an acute response in hematopoietic stem cells
but also established persisting epigenetic modifications in
myeloid lineage and innate immunity genes [80]. These
results prove that permanent epigenetic changes are induced
not only in the adaptive immune system but also in stem
cells of the innate immune system after an infection.
Conclusions and perspectives
A pandemic such as the ongoing SARS-COV-2 outbreak is
extremely stressful for all members of society, with long-
term outcomes, not only for those who have been actually
infected, but also for other people, who are not necessarily
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infected themselves, but who may suffer lasting con-
sequences as a result of loss, grief, isolation, deprivation,
and other psychological outcomes of ongoing quarantine or
shelter in place measures. This includes health care workers,
and others whose lives were severely affected.
The impact of multiple supportive and experimental
treatments also needs to be considered. Many of these affect
the endocrine stress axis, which again might lead to long-
term consequences. From earlier coronavirus outbreaks, it is
evident that survivors and health care workers are at
increased risk of developing mental illness years after the
outbreak. Such long-lasting impacts might be due to mor-
phological changes in the brain and in the organs of the
HPA axis. They could also be influenced by permanent
epigenetic changes in stem cells as induced by the actual
infection or the different forms of severe stress. Further-
more, sex differences in response to stress should be con-
sidered. All together these mechanisms could contribute to
the increased risk of developing mental disorders after a
pandemic such as COVID-19. Because of this enhanced
long-term susceptibility to mental illness, it is imperative to
monitor affected populations for an extended time during
the course of, as well as after, the current and devastating
COVID-19 pandemic.
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